The CD34(+) Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

The effect of CD34(+) cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft-versus-host disease (GvHD) has not been established and few studies have been performed. Our single center analysis included 189 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Remberger, M., Grønvold, B., Ali, M., Mattsson, J., Egeland, T., Lundin, K. U., Myhre, A., Abrahamsen, I., Heldal, D., Dybedal, I., Tjønnfjord, G. E., Gedde-Dahl, T., Fløisand, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432346/
https://www.ncbi.nlm.nih.gov/pubmed/34595446
http://dx.doi.org/10.2991/chi.d.200221.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432346/
https://www.ncbi.nlm.nih.gov/pubmed/34595446
http://dx.doi.org/10.2991/chi.d.200221.001

Ejemplares similares